Last reviewed · How we verify

NCT02066337

Effect of Ozone Gel on Alveolar Bone Density and Superoxide Dismutase in Chronic Periodontitis: A Randomized Controlled Clinical Study

Completed Phase 2 Last updated 19 February 2014
What this trial tests

Phase 2 trial testing scaling and root planing in Periodontal Diseases in 40 participants. Completed in 1 February 2014.

Timeline
1 March 2013
Primary endpoint
1 January 2014
1 February 2014

Quick facts

Lead sponsorOctober 6 University
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment40
Start date1 March 2013
Primary completion1 January 2014
Estimated completion1 February 2014
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

October 6 University

Who can join

Adults 30 to 60, any sex, with Periodontal Diseases. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

To evaluate the efficacy of locally delivered ozone gel as an adjunct to conventional periodontal therapy on selected clinical parameters as well as alveolar bone density (BD) and superoxide dismutase (SOD) activity in patient with chronic periodontitis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of scaling and root planing

Trials testing the same drug.

Other recruiting trials for Periodontal Diseases

Currently open trials in the same condition.

Other October 6 University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02066337.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing